Human immunopathogenesis of severe acute respiratory syndrome (SARS)

Cited by (386)

Items 101–200 of 386

1. The dual role of toll-like receptors in COVID-19: Balancing protective immunity and immunopathogenesis
   Payam Behzadi, Deepak Chandran, Chiranjib Chakraborty, Manojit Bhattacharya, Guttula Saikumar, Kuldeep Dhama, Ankita Chakraborty, Suprabhat Mukherjee, Meysam Sarshar · 2024 · International Journal of Biological Macromolecules
2. Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID) management
   Amjad Masood Husaini, Khan Nadiya Jan, Gowher A. Wani · 2021 · Heliyon
3. Genetic influences on viral-induced cytokine responses in the lung
   Jessica L. Forbester, Ian Robert Humphreys · 2020 · Mucosal Immunology
4. COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
   Masoud Etemadifar, Nahad Sedaghat, Ali Aghababaee, Parisa K Kargaran, Mohammad Reza Maracy, Mazdak Ganjalıkhani-Hakemi, Milad Rayani, Amir Parsa Abhari, Reza Khorvash, Mehri Salari et al. · 2021 · Multiple Sclerosis and Related Disorders
5. Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients
   Rasoul Abdollahzadeh, Mohammad Hossein Shushizadeh, Mina Barazandehrokh, Sepideh Choopani, Asaad Azarnezhad, Sahereh Paknahad, Maryam Pirhoushiaran, S. Zahra Makani, Razieh Zarifian Yeganeh, Ahmed Al-Kateb et al. · 2021 · Infection Genetics and Evolution
6. Chronic Stress and Depression in Periodontitis and Peri-Implantitis: A Narrative Review on Neurobiological, Neurobehavioral and Immune–Microbiome Interplays and Clinical Management Implications
   Francesco D’Ambrosio, Mario Caggiano, Luigi Schiavo, Giulia Savarese, Luna Carpinelli, Alessandra Amato, Alfredo Iandolo · 2022 · Dentistry Journal
7. Comparison of Associations Between Glucocorticoids Treatment and Mortality in COVID-19 Patients and SARS Patients: A Systematic Review and Meta-Analysis
   Jianbo Li, Xuelian Liao, Yue Zhou, Luping Wang, Hang Yang, Wei Zhang, Zhongwei Zhang, Yan Kang · 2021 · Shock
8. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It
   Stefano Cappanera, Michele Palumbo, Sherman H. Kwan, Giulia Priante, Lucia Assunta Martella, Lavinia Maria Saraca, Francesco Sicari, Carlo Vernelli, Cinzia Di Giuli, P. Andreani et al. · 2021 · Journal of Clinical Medicine
9. The Expression of IL-6, TNF- α , and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
   Jingtong Zheng, Yue Xi Shi, Lingxin Xiong, Weijie Zhang, Ying Li, Peter G. Gibson, Jodie Louise Simpson, Chao Zhang, Junying Lu, Jingying Sai et al. · 2017 · Journal of Immunology Research
10. Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling
    Bharath Kumar Gajjela, Ming‐Ming Zhou · 2021 · Drug Discovery Today
11. Renin-angiotensin system in human coronavirus pathogenesis
    Wevers, Brigitte A, Hoek, Lia van der · 2010 · Future Virology
12. Corona health-care warriors in India: knowledge, attitude, and practices during COVID-19 outbreak
    Rajesh Kumar, Vanya Singh, Aroop Mohanty, Yogesh Arvind Bahurupi, Puneet Kumar Gupta · 2021 · Journal of Education and Health Promotion
13. Lung fibrosis: Post-COVID-19 complications and evidences
    Rishabh Hirawat, Namrata Jain, Mohd Aslam Saifi, Mahesh Rachamalla, Chandraiah Godugu · 2022 · International Immunopharmacology
14. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice
    Zhihao San, Yunhe Fu, Wei Li, Ershun Zhou, Yimeng Li, Xiaojing Song, Tiancheng Wang, Tian Yuan, Zhengkai Wei, Minjun Yao et al. · 2014 · International Immunopharmacology
15. Immunopathogenesis of COVID-19 and early immunomodulators
    Kyung‐Yil Lee, Jung Woo Rhim, Jin-Han Kang · 2020 · Korean Journal of Pediatrics
16. A Human Lung Xenograft Mouse Model of Nipah Virus Infection
    Gustavo Valbuena, Hailey Halliday, Viktoriya Borisevich, Yenny Góez, Barry Rockx · 2014 · PLoS Pathogens
17. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
    Esther Moga, Elionor Lynton‐Pons, Peré Domingo · 2022 · Frontiers in Immunology
18. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis
    Chao Quan, Caiyan Li, Han Ma, Yisha Li, Huali Zhang · 2020 · Clinical Microbiology Reviews
19. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients
    Alok Raghav, Zeeshan Ahmad Khan, Viabhav Kumar Upadhayay, Prashant Tripathi, Kirti Amresh Gautam, Brijesh Kumar Mishra, Jamal Ahmad, Goo‐Bo Jeong · 2021 · Cells
20. Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis
    Ayat Zawawi, Abdallah Y. Naser, Hassan H Alwafi, Faisal Minshawi · 2021 · Frontiers in Immunology
21. SARS‐CoV‐2‐reactive interferon‐γ‐producing CD8+ T cells in patients hospitalized with coronavirus disease 2019
    Estela Giménez, Eliseo Albert, Ignacio Torres, María José Remigia, María Jesús Alcaráz, María José Galindo, María Luisa Blasco, Carlos Solano, María José Forner, Josep Redón et al. · 2020 · Journal of Medical Virology
22. Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
    Rishabh Hirawat, Mohd Aslam Saifi, Chandraiah Godugu · 2020 · Life Sciences
23. Recent advances in vaccine and immunotherapy for COVID-19
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Jaffar A. Al‐Tawfiq, Ayman M. Al‐Qaaneh, Lamiaa Hamad Al-Jamea, Alexander Woodman, Manaf AlQahtani, Shafiul Haque, Harapan Harapan et al. · 2020 · Human Vaccines & Immunotherapeutics
24. Peculiarities of the T Cell Immune Response in COVID-19
    Dmitry Anatolievich Kudlay, И.А. Кофиади, Musa Rakhimovich Khaitov · 2022 · Vaccines
25. Cytokine Response in SARS-CoV-2 Infection in the Elderly
    Subuhi Sherwani, Mohd Wajid Ali Khan · 2020 · Journal of Inflammation Research
26. Regulation of cell death during infection by the severe acute respiratory syndrome coronavirus and other coronaviruses
    Yee‐Joo Tan, Seng Gee Lim, Wanjin Hong · 2007 · Cellular Microbiology
27. Ramadan Fasting During the COVID-19 Pandemic; Observance of Health, Nutrition and Exercise Criteria for Improving the Immune System
    Majid Taati Moghadam, Behzad Taati, Seyed Mojtaba Paydar Ardakani, Katsuhiko Suzuki · 2021 · Frontiers in Nutrition
28. Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2
    William James Melvin, Christopher O. Audu, Frank M. Davis, Sriganesh B. Sharma, Amrita Joshi, Aaron D. denDekker, Sonya Wolf, Emily C. Barrett, Kevin Dale Mangum, Xiaofeng Zhou et al. · 2021 · Proceedings of the National Academy of Sciences
29. Characterization of anti-viral immunity in recovered individuals infected by SARS-CoV-2
    Ling Ni, Fang Ye, Mengli Chen, Feng Yu, Yong‐Qiang Deng, Hui John Zhao, Wei Peng, Jiwan Ge, Xiaoli Li, Lin Sun et al. · 2020 · medRxiv
30. NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.
    Debashis Dutta, Jianuo Liu, Huangui Xiong · 2022 · PubMed Central
31. Literature-related discovery: Potential treatments and preventatives for SARS
    Ronald Neil Kostoff · 2011 · Technological Forecasting and Social Change
32. COVID-19 and Heart: From Clinical Features to Pharmacological Implications
    Vincenzo Russo, Roberta Bottino, Andreina Carbone, Anna Rago, Andrea Antonio Papa, Paolo Golino, Gerardo Nigro · 2020 · Journal of Clinical Medicine
33. Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
    Ashley A. Stegelmeier, Maedeh Darzianiazizi, Kiersten Hanada, Shayan Sharif, Sarah K. Wootton, Byram W. Bridle, Khalil Karimi · 2021 · International Journal of Molecular Sciences
34. Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
    Vivek P. Chavda, Normi D. Gajjar, Nirav Shah, Divyang J. Dave · 2021 · European Journal of Medicinal Chemistry Reports
35. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19
    Holger A. Lindner, Sonia Y. Velásquez, Manfred Thiel, Thomas Kirschning · 2021 · Frontiers in Immunology
36. Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity
    Rosalinda Posadas‐Sánchez, Fausto Sánchez‐Muñoz, Carlos Alfonso Guzmán-Martín, Adrián Hernández-Díazcouder, Gustavo Rojas Velasco, José Manuel Fragoso, Gilberto Vargas‐Alarcón · 2021 · Life Sciences
37. Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity
    Eman A. Alefishat, Herbert Franz Jelinek, Mira Mousa, Guan K. Tay, Habiba S. AlSafar · 2022 · Journal of Infection and Public Health
38. The relationship between coronary artery disease and clinical outcomes in COVID-19: a single-center retrospective analysis
    Eric Peterson, Kevin Bryan Lo, Robert DeJoy, Grace Salacup, Jerald Pelayo, Ruchika Bhargav, Fahad Gul, Jeri Albano, Zurab Azmaiparashvili, Aman M. Amanullah et al. · 2020 · Coronary Artery Disease
39. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review
    Akram Yarmohammadi, Mostafa Yarmohammadi, S. Fakhri, H. Khan · 2020 · European Journal of Pharmacology
40. Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19
    Nidhi Singh, Sachchida Nand, Veer Singh, Mohan Prasad Singh · 2020 · Journal of Chemical Neuroanatomy
41. Relationship Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Etiology of Acute Kidney Injury (AKI)
    Woon Hean Chong, Biplab Kumar Saha · 2020 · The American Journal of the Medical Sciences
42. JAK inhibition as a new treatment strategy for patients with COVID-19
    Jin Huang, Chi Zhou, Deng Jinniu, Jianfeng Zhou · 2022 · Biochemical Pharmacology
43. COVID‐19: Emergence of Infectious Diseases, Nanotechnology Aspects, Challenges, and Future Perspectives
    Akanksha Gupta, Sanjay Kumar, Ravinder Kumar, Ashish Kumar Choudhary, Kamlesh Kumari, Prashant Singh, Vinod Kumar · 2020 · ChemistrySelect
44. Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies
    Yi-Ting Fang, Chiou‐Feng Lin, Pao‐Chi Liao, Yu‐Min Kuo, Shuying Wang, Trai‐Ming Yeh, Chi-Chang K. Shieh, Ih‐Jen Su, Huan-Yao Lei, Yee-Shin Lin · 2009 · Molecular Immunology
45. Immunological aspects of COVID-19: What do we know?
    Tsvetelina Veselinova Velikova, Stanislav Vasilev Kotsev, D Georgiev, Hristiana Batselova · 2020 · World Journal of Biological Chemistry
46. Silent hypoxia: higher NO in red blood cells of COVID-19 patients
    Esmaeil Mortaz, Majid Malkmohammad, Hamidreza Jamaati, Parisa Adimi Naghan, Seyed Mohammadreza Hashemian, Payam Tabarsi, Maohammad Varahram, Hamidreza Zaheri, Efsun Gonca Uğur Chouseın, Gert Folkerts et al. · 2020 · BMC Pulmonary Medicine
47. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
    Patrick O’Connell, Yasser Ali Aldhamen · 2020 · Human Vaccines & Immunotherapeutics
48. Immunopathogenic properties of SARS-CoV-2 as a basis for the choice of pathogenetic therapy
    ", M.P. Kostinov · 2020 · Immunologiya
49. Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses
    Sourav Dutta, Nilanjana Das, Piyali Mukherjee · 2020 · Frontiers in Microbiology
50. A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza
    Julie C. F. Rappe, Katja Finsterbusch, Stefania Crotta, Matthias Mack, Simon Lawrence Priestnall, Andreas Wack · 2021 · The Journal of Experimental Medicine
51. Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19
    Antonio Vitiello, Raffaele La Porta, Francesco Ferrara · 2021 · Medical Hypotheses
52. Innate immunity in coronavirus infection
    В. С. Смирнов, Areg A. Totolyan · 2020 · Russian Journal of Infection and Immunity
53. Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains
    Alberto Jose Leon, Viktoriya Borisevich, Nahal Boroumand, Robert L. Seymour, Rebecca J. Nusbaum, Olivier Escaffre, Luoling Xu, David J. Kelvin, Barry Rockx · 2018 · PLoS neglected tropical diseases
54. MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression
    Hatem A. Mohamed, Aya Eid Abdelkafy, Rasha M. M. Khairy, Salama R. Abdelraheim, Bothina Ahmed Kamel, Heba Marey · 2023 · Scientific Reports
55. Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective
    Alaa Alnefaie, Sarah M. Albogami · 2020 · Saudi Pharmaceutical Journal
56. Immune Correlates of COVID-19 Control
    Bhawna Poonia, Shyam Kottilil · 2020 · Frontiers in Immunology
57. Neuroinvasive potential of SARS‐CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim?
    Raduan Ahmed Franca, Lorenzo Ugga, Elia Guadagno, Daniela Russo, Marialaura Del Basso De · 2020 · Apmis
58. Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19)
    Banlambhabok Khongthaw, Kanika Dulta, P.K. Chauhan, Vinod Kumar, Joshua O. Ighalo · 2022 · Inflammopharmacology
59. Immune-Based Therapy for COVID-19
    Abdolreza Esmaeilzadeh, Davood Jafari, Safa Tahmasebi, Reza Elahi, Elnaz Khosh · 2021 · Advances in experimental medicine and biology
60. Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19
    Dana Rose Julian, Megan A. Kazakoff, Akhil Patel, Jesse M. Jaynes, Monte S. Willis, Cecelia Chrsitina Yates · 2021 · Current Pathobiology Reports
61. The striking mimics between COVID-19 and malaria: A review
    Emadeldin Hassan E. Konozy, Makarim Elfadil M. Osman, George Ghartey‐Kwansah, Hind Mohamed Abushama · 2022 · Frontiers in Immunology
62. Repurposing Existing Drugs for the Treatment of COVID-19
    Hugo Andres Farne, Kartik Kumar, Andrew I. Ritchie, Lydia Finney, Sebastian Lennox Johnston, Aran Singanayagam · 2020 · Annals of the American Thoracic Society
63. COVID-19: Physiopathology and Targets for Therapeutic Intervention
    Juliana O. de Almeida, Victoria Regina T. de Oliveira, João Lucas dos S. Avelar, Bruna Simões Moita, Lı́dia Moreira Lima · 2020 · Revista Virtual de Química
64. Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2
    Diana García-del-Barco, Daniela Risco-Acevedo, Jorge Berlanga‐Acosta, Frank Daniel Martos-Benítez, Gerardo E Guillén · 2021 · Frontiers in Immunology
65. COVID‐19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations
    Marek Jutel, María José Torres, Óscar Palomares, Cezmi A. Akdiş, Thomas Eiwegger, Eva Untersmayr, Domingo Barber, Magdalena Zemelka‐Wiącek, Anna Kosowska, Elizabeth N. Palmer et al. · 2022 · Allergy
66. Humoral response to mRNA ‐based COVID ‐19 vaccine in patients with myeloid malignancies
    Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Haruna Muraki, Masanobu Morioka, Takanori Teshima et al. · 2022 · British Journal of Haematology
67. Long COVID-19: Psychological symptoms in COVID-19 and probiotics as an adjunct therapy
    Angel Yun-Kuan Thye, Loh Teng‐Hern Tan, Jodi Woan‐Fei Law, Priyia Pusparajah, Vengadesh Letchumanan · 2022 · Progress In Microbes & Molecular Biology
68. Viral Infection is Associated with an Increased Proinflammatory Response in Chronic Obstructive Pulmonary Disease
    Raquel Almansa, Lorenzo Socías, David Andaluz‐Ojeda, Ignacio Martín‐Loeches, Felipe Bobillo, Jesús Blanco, Lucía Rico, José Ángel Berezo, Ángel Estella, Monica Sanchez-Garcia et al. · 2012 · Viral Immunology
69. Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome?
    Carmela Falcone, Massimo Caracciolo, Pierpaolo Correale, Sebastiano Macheda, Eugenio Giuseppe Vadalà, Stefano La Scala, Marco Tescione, Roberta Danieli, Anna Ferrarelli, Maria Grazia Tarsitano et al. · 2020 · Journal of Clinical Medicine
70. A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic
    Tofael Ahmed Sumon, Md. Ashraf Hussain, Md Tawheed Hasan, Mahmudul Hasan, Won Je Jang, Eleus Hussain Bhuiya, Abdullah Al Mamun Chowdhury, S.M. Sharifuzzaman, Christopher Lyon Brown, Hyun‐Ju Kwon et al. · 2021 · Frontiers in Molecular Biosciences
71. Clinical Characterization and Possible Pathological Mechanism of Acute Myocardial Injury in COVID-19
    Siyi Li, Jinan Wang, Yan Yan, Zekun Zhang, Wei Gong, Shaoping Nie · 2022 · Frontiers in Cardiovascular Medicine
72. Causes of Hypoxemia in COVID-19
    Zh. A. Donina · 2022 · Journal of Evolutionary Biochemistry and Physiology
73. Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?
    Daniele Giammaria, Alessandro Pajewski · 2020 · Journal of Global Health
74. Cell-cycle-gated feedback control mediates desensitization to interferon stimulation
    Anusorn Mudla, Yanfei Jiang, Kei‐ichiro Arimoto, Bingxian Xu, Adarsh Rajesh, Andy P Ryan, Wei Wang, Matthew D. Daugherty, Dong‐Er Zhang, Nan Hao · 2020 · eLife
75. An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19
    Kobra Ziyaei, Zahra Ataie, Majid Mokhtari, Kelvin Adrah, Mohammad Ali Daneshmehr · 2022 · International Journal of Biological Macromolecules
76. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study
    Liang Xie, Qinhan Wu, Qunying Lin, Xuhui Liu, Weihua Lin, Shengyu Hao, Weiping Hu, Guiling Xiang, Hongzhou Lu, Shanqun Li · 2020 · Therapeutic Advances in Respiratory Disease
77. Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection
    Xianfang Liu, Longquan Lou, Lei Zhou · 2022 · Frontiers in Cardiovascular Medicine
78. Nanoligomers Targeting Human miRNA for the Treatment of Severe COVID-19 Are Safe and Nontoxic in Mice
    Colleen R. McCollum, Colleen M. Courtney, Nolan J. O’Connor, Thomas R. Aunins, Yuchen Ding, Tristan X. Jordan, Keegan L. Rogers, Stephen M. Brindley, Jared M. Brown, Prashant Nagpal et al. · 2022 · ACS Biomaterials Science & Engineering
79. The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19
    Ananda Shiva Prasad, Agnes Malysa, Gerold Bepler, Andrew M. Fribley, Bin Bao · 2022 · Antioxidants
80. Cloning, expression and characterization of ferret CXCL10
    Ali Danesh, Charit Seneviratne, Cheryl Cameron, David Banner, Mark E. DeVries, Alyson A. Kelvin, Luoling Xu, Longsi Ran, Steven E. Bosinger, Thomas Rowe et al. · 2007 · Molecular Immunology
81. SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19
    Mario Fernández‐Ruiz, Beatriz Olea, Estela Giménez, Rocío Laguna‐Goya, Hernando Trujillo, Fernando Caravaca‐Fontán, Eduardo Gutiérrez, Francisco López‐Medrano, María José Remigia, Patricia Almendro-Vázquez et al. · 2021 · Transplantation
82. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates
    Sajad Fakhri, Zeinab Nouri, Seyed Zachariah Moradi, Esra Küpeli Akkol, Sana Piri, Eduardo Sobarzo‐Sánchez, Mohammad Hosein Farzaei, Javier Echeverría · 2021 · Molecules
83. SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches
    Ramalingam Karthik Raja, Phuong Nguyen‐Tri, Govindasamy Balasubramani, A. Arun, Selçuk Hazır, Safa Ladhari, Alireza Saïdi, Arivalagan Pugazhendhi, Arulandhu Anthoni Samy · 2021 · Applied Nanoscience
84. Cardiac and arrhythmic complications in Covid-19 patients.
    Adriano Nunes Kochi · 2020
85. Cinnamon: A Promising Natural Product Against COVID-19
    Azadeh Zareie, Davood Soleimani, Gholamreza Askari, Tannaz Jamialahmadi, Paul C. Guest, Mohammad Bagherniya, Amirhossein Sahebkar · 2021 · Advances in experimental medicine and biology
86. Roles of steroid receptors in the lung and COVID-19
    Damien A. Leach, Greg Nicholas Brooke, Charlotte Lynne Bevan · 2021 · Essays in Biochemistry
87. Immune Profiling of COVID-19 in Correlation with SARS and MERS
    Bariaa A. Khalil, Sarra B. Shakartalla, Swati Goel, Bushra Mdkhana, Rabih Halwani, Azzam A. Maghazachi, Habiba S. AlSafar, Basem Al‐Omari, Mohammad Tahseen Al Bataineh · 2022 · Viruses
88. Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid‐19 patients
    Ufuk Oğuz İdiz, Tahir Talat Yurttaş, Şerife Değirmencioğlu, Bağnu Orhan, Emre Erdoğan, Hüsnü Şevik, Mert Mahsuni Sevinc · 2022 · Journal of Medical Virology
89. Altered endochondral ossification in collagen X mouse models leads to impaired immune responses
    Elizabeth A. Sweeney, M. Campbell, K. Watkins, Christopher A. Hunter, Olena Jacenko · 2008 · Developmental Dynamics
90. COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach
    Soha R. Abd El Hadi, Esmat E Zien El-Deen, Mostafa M. Bahaa, Abdelfattah A. Sadakah, Heba Yassin · 2021 · Drug Design Development and Therapy
91. Sleep disturbances following recovery from COVID-19: a comparative cross-sectional study in Egypt
    Mohamed Abdelghani, Maha E. Alsadik, Ahmed A. Abdelmoaty, Samar A. Atwa, Amira Said, Mervat S. Hassan · 2022 · Eastern Mediterranean Health Journal
92. Molecular basis of COVID-19 pathogenesis
    Fedor N. Novikov, Viktor S. Stroylov, Igor V. Svitanko, Vladimir E. Nebolsin · 2020 · Russian Chemical Reviews
93. COVID-19 versus SARS: A comparative review
    Ahmed S. Keshta, Saad I. Mallah, Khaled Al Zubaidi, Omar Khaled Hassan Attia Ghorab, Mohamed S. Keshta, Dalal Alarabi, Mohammad A Abousaleh, Mustafa Thaer Salman, Omer E. Taha, Anas A. Zeidan et al. · 2021 · Journal of Infection and Public Health
94. Immunopathogenesis of 2009 pandemic influenza
    Raquel Almansa, Jesús F. Bermejo-Martín, Raúl Ortiz de Lejarazu Leonardo · 2012 · Enfermedades Infecciosas y Microbiología Clínica
95. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective
    Md Bashir Uddin, Mahmudul Hasan, Ahmed Harun‐Al‐Rashid, Md. Irtija Ahsan, Md. Abdus Shukur Imran, Syed Sayeem Uddin Ahmed · 2020 · Infection Genetics and Evolution
96. Serum levels of type I interferon (IFN-I) is associated with the severity of COVID-19
    Yuting Sun, Gang Wang, Rongshuai Wang, Liang Ren, Zilin Yuan, Yueping Liu, Yuzhang Wu, Rong Chen, Yongwen Chen, Bo Diao · 2023 · Journal of Medical Microbiology
97. Potential of algal metabolites for the development of broad‐spectrum antiviral therapeutics: Possible implications in COVID ‐19 therapy
    Rimjhim Sangtani, Atreyee Ghosh, Hem Chandra Jha, Hamendra Singh Parmar, Kiran Bala · 2020 · Phytotherapy Research
98. Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review
    David Banji, Saad S. Alqahtani, Otilia J.F. Banji, Shamna Machanchery, Ambreen Shoaib · 2021 · Saudi Pharmaceutical Journal
99. The Swine IFN System in Viral Infections: Major Advances and Translational Prospects
    Elisabetta Razzuoli, Federico Armando, Livia De Paolis, Małgorzata Ciurkiewicz, Massimo Amadori · 2022 · Pathogens
100. Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
     Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, Luca Marsili, Anne Michele Slavotinek, Daniel R. Prows, Robert James Hopkin, Mary Ashley McKay, Manoj K. Pandey · 2022 · International Journal of Molecular Sciences